Strategic Acquisition Recent asset sale to Bioness Medical indicates potential strategic consolidation in the neurorehabilitation robotics space. This creates a sales window for compatible Harmony SHR assets, service agreements, or migration paths for existing customers affected by the acquisition.

Hospital Entry Commercial launch in a top neurological hospital in Phoenix signals validated clinical interest and payer-ready value proposition. Target similar large neurology and rehabilitation centers for expansion, leveraging reference site outcomes and clinician testimonials.

Global Expansion Distribution partnerships with Healthlink Holdings in Hong Kong and Macau open opportunities to scale into Asia-Pacific markets. Pursue regional distributors or direct sales to leading hospitals and rehab centers to capitalize on early adoption momentum.

Financial Levers Moderate revenue range with recent funding support suggests readiness for pilot programs, fleet deployments, or favorable financing options for healthcare facilities. Offer bundled financing, ROI cases, and trial deployments to accelerate signings.

Clinical Value Harmony SHR enables objective measurement across baseline and recovery, appealing to research institutions and care facilities focused on data-driven therapy outcomes. Develop partnerships with universities and rehab centers for trials, registries, and long-term procurement contracts.